Tokushima, Japan

Chiharu Kitajima


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Chiharu Kitajima: Contributions to Carbostyril Compounds

Introduction: Chiharu Kitajima is a distinguished inventor based in Tokushima, Japan, known for her significant contributions to the field of pharmaceuticals. With a total of two patents to her name, Kitajima has made advancements that hold the potential to address a variety of medical conditions.

Latest Patents: Among her recent innovations is a novel carbostyril compound that is designed to induce the production of TFF (trefoil factor family). This compound, represented by a specific general formula, offers potential therapeutic benefits for treating alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds. The detailed structure of this invention includes parameters like A being a direct bond, a lower alkylene group, or a lower alkylidene group, with X being either an oxygen or sulfur atom.

Career Highlights: Chiharu Kitajima is currently associated with Otsuka Pharmaceutical Company, Limited, where her innovative research supports the company's mission to improve health outcomes through cutting-edge pharmaceuticals. Her work, particularly in the realm of carbostyril compounds, has demonstrated significant potential for developing new treatments for various diseases.

Collaborations: Kitajima collaborates with talented colleagues, including Takeshi Kuroda and Takahito Yamauchi. Together, they leverage their expertise to advance research and development within their organization, fostering an environment of innovation and discovery.

Conclusion: Chiharu Kitajima stands out as a leading figure in pharmaceutical innovation, particularly with her work on carbostyril compounds. Her dedication to research and collaboration continues to pave the way for new treatments that could potentially transform patient care and improve therapeutic options for a range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…